4SC AG 0M64

Last Price
-

Day Change
-|-%

As of -
| EUR Minimum 15 Minutes Delay.

Bid/Offer	Day Range	Volume	90d Ave Vol	Mkt Cap
- - -	-	-	-	105.8 Mil

Last Close	52 Week Range	P/E	Yield %	ISIN
-	1.50 - 2.21	-	-	DE0005753818

4SC AG Share Price

more...

Financials
	Annual
	2010	2011	2012
more...
Income Statement
Revenue	1	1	4
Operating Income	-20	-19	-13
Net Income	-20	-19	-13
Basic EPS	-0.52	-0.46	-0.29
Avg. Diluted Shares Outstanding	39	41	46
Balance Sheet
Current Assets	19	17	16
Non Current Assets	16	15	13
Total Assets	35	32	29
Current Liabilities	3	4	3
Total Liabilities	4	8	7
Shareholder Equity	31	24	22
Cash Flow
Cash From Operations	-18	-12	-15
Capital Expenditure	0	-1	0
Free Cash Flow	-18	-13	-15

In millions, except "Basic EPS". Currency is EUR.

Company Profile

4SC AG researches and develops innovative, orally administered smallmolecule drugs for autoimmune diseases and cancer – indications with a high unmet medical need.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

Key Stats
more...
Price/Earning TTM	-
Price/Book	-
Price/Sales TTM	-
Rev Growth (3 year avg)	32.74
EPS Growth (3 year avg)	-
Operating Margin % TTM	-307.05
Net Margin % TTM	-303.63
ROE TTM	-58.29
Debt/Equity	1.33

Welcome to Morningstar.co.uk!

For more information: